Legal & General Group PLC Cytek Biosciences, Inc. Transaction History

Legal & General Group PLC

  • $431 Billion
  • Q3 2025

A detailed history of Legal & General Group PLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 192,375 shares of CTKB stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
192,375
Previous 310,291 38.0%
Holding current value
$1.06 Million
Previous $1.05 Million 36.72%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$3.1 - $4.17 $365,539 - $491,709
-117,916 Reduced 38.0%
192,375 $667,000
Q2 2025

Aug 12, 2025
BUY
$2.42 - $3.99 $32,578 - $53,713
13,462 Added 4.54%
310,291 $1.05 Million
Q1 2025

May 15, 2025
SELL
$4.0 - $7.26 $64,832 - $117,670
-16,208 Reduced 5.18%
296,829 $1.19 Million
Q4 2024

Feb 13, 2025
BUY
$4.7 - $7.4 $53,326 - $83,960
11,346 Added 3.76%
313,037 $2.03 Million
Q3 2024

Feb 28, 2025
SELL
$4.73 - $6.73 $97,906 - $139,304
-20,699 Reduced 6.61%
292,338 $1.62 Million
Q3 2024

Nov 14, 2024
BUY
$4.73 - $6.73 $60,841 - $86,567
12,863 Added 4.45%
301,691 $1.67 Million
Q2 2024

May 29, 2025
SELL
$5.3 - $6.91 $43,412 - $56,599
-8,191 Reduced 2.85%
279,475 $1.56 Million
Q2 2024

Aug 14, 2024
BUY
$5.3 - $6.91 $6,158 - $8,029
1,162 Added 0.4%
288,828 $1.61 Million
Q1 2024

May 29, 2025
SELL
$6.29 - $9.15 $57,635 - $83,841
-9,163 Reduced 3.09%
287,666 $1.93 Million
Q1 2024

May 14, 2024
SELL
$6.29 - $9.15 $6,919 - $10,065
-1,100 Reduced 0.38%
287,666 $1.93 Million
Q4 2023

May 29, 2025
SELL
$4.1 - $9.51 $33,058 - $76,679
-8,063 Reduced 2.72%
288,766 $2.63 Million
Q4 2023

Feb 15, 2024
BUY
$4.1 - $9.51 $39,585 - $91,819
9,655 Added 3.46%
288,766 $2.63 Million
Q3 2023

Nov 14, 2023
BUY
$5.52 - $9.5 $262,376 - $451,554
47,532 Added 20.53%
279,111 $1.54 Million
Q2 2023

Aug 14, 2023
BUY
$6.69 - $11.99 $1.3 Million - $2.33 Million
194,270 Added 520.71%
231,579 $1.98 Million
Q1 2023

May 15, 2023
BUY
$8.44 - $13.47 $12,060 - $19,248
1,429 Added 3.98%
37,309 $342,000
Q4 2022

Feb 14, 2023
BUY
$9.71 - $15.86 $4,126 - $6,740
425 Added 1.2%
35,880 $366,000
Q3 2022

Nov 14, 2022
SELL
$10.96 - $15.45 $46,021 - $64,874
-4,199 Reduced 10.59%
35,455 $522,000
Q2 2022

Aug 22, 2022
BUY
$7.41 - $11.56 $220,832 - $344,511
29,802 Added 302.5%
39,654 $425,000
Q1 2022

May 16, 2022
BUY
$9.89 - $17.25 $81,612 - $142,347
8,252 Added 515.75%
9,852 $106,000
Q3 2021

Nov 15, 2021
BUY
$17.52 - $27.93 $28,032 - $44,688
1,600 New
1,600 $34,000

Others Institutions Holding CTKB

# of Institutions
150
Shares Held
72.8M
Call Options Held
0
Put Options Held
0
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $740M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email